Scalable production of RNA for agriculture Andrey Zarur, Cofounder & CEO, GreenLight Biosciences Potassium fertilizer innovation Philip Wender, Managing Director, Advanced Potash Technologies Chemiresistive gas sensing for food safety Merry Smith, Senior Scientist, C2Sense Novel dehumidifying material for indoor farms Sorin Grama, Cofounder, Transaera Probiotics for plants Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]
Procter & Gamble is looking for new approaches and technologies that can help them to address key business challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Elbit America, a fast-growing defense company, is seeking technology partnership with startups in digital transformation, sonar / acoustics, HSA/DM, sensors, augmented reality, artificial intelligence / machine learning, optics, non GPS dependent precision north finding & non GPS dependent precision navigation and timing, precision Line of Sight (LOS) sensing, optical communications, and advanced video and image processing.
Trond Undheim, Program Director, MIT Startup Exchange
Alan Kriz - Open Innovation and Investment
Jan Schnorr, CEO, C2Sense
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.